Gastrointestinal melatonin: localization, function, and clinical relevance.
Level 5 - mechanism / opinion, no new human data
Narrative review of animal, mechanistic, and physiological literature without systematic review or original human trial data
PubMed 12395907 · doi:10.1023/a:1020107915919
What was done
Narrative review synthesizing comparative biology, physiological mechanisms, and preclinical evidence on the localization, release dynamics, and potential clinical relevance of extrapineal melatonin in the vertebrate gastrointestinal tract.
What was found
Melatonin concentrations in gastrointestinal tissues exceed circulating blood levels by 10- to 100-fold, and the total gastrointestinal pool contains at least 400 times more melatonin than the pineal gland. Unlike pineal melatonin, gastrointestinal release is primarily regulated by food intake patterns (with increases observed after feeding and during prolonged food deprivation) rather than light-dark cycles. Reported biological actions include reduction of gastrointestinal smooth muscle tone, inhibition of hydrochloric acid secretion, stimulation of mucosal microcirculation and epithelial regeneration, and antioxidant-mediated mucosal protection.
Why it matters
This review establishes the gastrointestinal tract as a major extrapineal source of melatonin with autonomous, nutrition-dependent regulatory functions. It outlines mechanistic rationales for investigating melatonin in conditions such as peptic ulcer disease, inflammatory bowel disease, irritable bowel syndrome, and colorectal neoplasia.
Limits
The abstract describes a broad narrative synthesis without systematic search methods, defined study selection criteria, or quality assessment. The majority of cited findings reflect animal, embryonic, or bench mechanistic models; no human clinical trial data, sample sizes, or therapeutic outcome measurements are provided.
Cited by
- context Most melatonin synthesized in the human body is produced in the gastrointestinal tract from serotonin.